Tetanus Surveillance - United States, 1991-1994

Morbidity and Mortality Weekly Report

Volumn 46, Issue SUPPL. 2, 1997, Pages 15-25

  Izurieta, Hector S ^a   Sutter, Roland W ^a   Strebel, Peter M ^a   Bardenheier, Barbara ^a   Prevots, D Rebecca ^a   Wharton, Melinda ^a   Hadler, Stephen C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; TETANUS ANTIBODY; TETANUS TOXOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; MIDDLE AGED; PRESCHOOL CHILD; TETANUS; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFANT; MIDDLE AGED; POPULATION SURVEILLANCE; TETANUS; TETANUS ANTITOXIN; TETANUS TOXOID; UNITED STATES; VACCINATION;

EID: 0347052959     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hinman AR, Orenstein WA, Bart KJ, Preblud SR. Immunization. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone Inc., 1990:2320-34.
2. CDC. Summary of notifiable diseases, United States, 1990. MMWR 1991;39(No. 53):55-61.
3. Taeuber IB. The changing distribution of the population of the United States in the Twentieth Century. In: Mazie SM, ed. U.S., Commission on Population Growth and the American Future: population distribution and policy. Vol V. Commission research reports. Washington, DC: Government Printing Office, 1972.
4. CDC. State immunization requirements, 1993-1994. Atlanta: US Department of Health and Human Services, Public Health Service, CDC, 1993.
5. CDC. Reported vaccine-preventable diseases - United States, 1993, and the Childhood Immunization Initiative. MMWR 1994;43:57-60.
6. CDC. State and national vaccination coverage levels among children aged 19-35 months -United States, April-December 1994. MMWR 1995;44:619-23.
7. ACIP. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. MMWR 1991;40(No. RR-10).
8. CDC. Case definitions for public health surveillance. MMWR 1990;39(No. RR-13).
9. Blake PA, Feldman RA, Buchanan TM, Brooks GF, Bennett JV. Serologic therapy of tetanus in the United States, 1965-1971. JAMA 1976;235:42-4.
10. CDC. Tetanus - United States, 1982-1984. MMWR 1985:34:602,607-11.
11. CDC. Tetanus - United States, 1985-1986. MMWR 1987;36:477-81.
12. CDC. Tetanus - United States, 1987 and 1988. MMWR 1990;39:37-41.
13. Prevots R, Sutter RW, Strebel PM, Cochi SL, Hadler S. Tetanus surveillance - United States, 1989-1990. In: CDC surveillance summaries (December). MMWR 1992;41(No. SS-8):1-9.
14. Remington RD, Schork MA. Statistics with applications to the biological and health sciences. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, Inc., 1985:187-8, 313-6.
15. CDC. Tetanus - Kansas, 1993. MMWR 1994;43:309-11.
16. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761-6.
17. Ruben FL, Nagel J, Fireman P. Antitoxin responses in the elderly to tetanus-diphtheria (Td) immunization. Am J Epidemiol 1978;108:145-9.
18. Crossley K, Irvine P, Warren JB, Lee BK, Mead K. Tetanus and diphtheria immunity in urban Minnesota adults. JAMA 1979;242:2298-300.
19. Weiss BP, Strassburg MA, Feeley JC. Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health 1983;73:802-4.
20. Scher KS, Baldera A, Wheeler WE, Walker R, Jones CW. Inadequate tetanus protection among the rural elderly. South Med J 1985;78:153-6.
21. Edsall G. Specific prophylaxis of tetanus. JAMA 1959;171:125-35.
22. Edmondson RS, Flowers MW. Intensive care in tetanus: management, complications, and mortality in 100 cases. Br Med J 1979;1:1401-4.
23. Humber G, Fillastre J-P, Dordain M, Leroy J, Robert M, Delauney P. 100 Cases of tetanus. Scand J Infect Dis 1972;4:129-31.
24. Alfery DD, Rauscher LA. Tetanus: a review. Crit Care Med 1979;7:176-81.
25. Sutter RW, Cochi SL, Brink EW, Sirotkin BI. Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. Am J Epidemiol 1990; 131:132-42.
26. da Silveira CM, de Quadros CA. Neonatal tetanus: countdown to 1995. World Health Forum 1991;12:289-96.
27. Global Advisory Group, Expanded Programme on Immunization, World Health Organization. Achieving the major disease control goals. Wkly Epidemiol Rec 1994;69:29-31,34-5.
28. CDC. Progress toward the global elimination of neonatal tetanus, 1989-1993. MMWR 1994; 43:885-7, 893-4.
29. Wassilak SGF, Orenstein WA, Sutter RW. Tetanus toxoid. Chapter 4. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines. 2nd ed. Philadelphia: W.B. Saunders Co., 1994:57-90.
30. Mellinger AK, Cragan JD, Atkinson WL, et al. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr Infect Dis J 1995;14:573-8.
31. Fedson DS, National Vaccine Advisory Committee. Adult immunization: summary of the National Vaccine Advisory Committee report. JAMA 1994;272:1133-7.
32. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1988; 108:616-25.
33. CDC. Assessing adult vaccination status at age 50 years. MMWR 1995;44:561-3.
34. CDC. Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR 1996;45(No. RR-13).
35. CDC. Recommended childhood immunization schedule - United States, January 1995. MMWR 1995;43:959-60.